Page last updated: 2024-08-21

2-aminopurine and Metastase

2-aminopurine has been researched along with Metastase in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Pan, Y; Qin, Y; Xiang, R; Yang, J; Yang, SY; Zheng, M; Zhong, L; Zhou, S	1
Galjour, J; Marchetti, D; Murry, B; Wilke-Greiter, A	1

Other Studies

2 other study(ies) available for 2-aminopurine and Metastase

Article	Year
A preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer. Molecular cancer therapeutics, 2015, Volume: 14, Issue:2 Topics: 2-Aminopurine; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Evaluation, Preclinical; ErbB Receptors; Female; G1 Phase; Humans; Mice, Nude; Neoplasm Metastasis; Pancreatic Neoplasms; Piperazines; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Recombinant Proteins; Resting Phase, Cell Cycle; Signal Transduction; src-Family Kinases; Vascular Endothelial Growth Factor Receptor-2; Zebrafish	2015
Human melanoma TrkC: its association with a purine-analog-sensitive kinase activity. Journal of cellular biochemistry, 2003, Apr-01, Volume: 88, Issue:5 Topics: 2-Aminopurine; Brain Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Melanoma; Neoplasm Metastasis; Neurotrophin 3; Protein Kinases; Protein Serine-Threonine Kinases; Receptor, Nerve Growth Factor; Receptor, trkC; Receptors, Nerve Growth Factor; Signal Transduction; Thioguanine; Time Factors	2003

Article

Year

A preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer.

Molecular cancer therapeutics, 2015, Volume: 14, Issue:2

Topics: 2-Aminopurine; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Evaluation, Preclinical; ErbB Receptors; Female; G1 Phase; Humans; Mice, Nude; Neoplasm Metastasis; Pancreatic Neoplasms; Piperazines; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Recombinant Proteins; Resting Phase, Cell Cycle; Signal Transduction; src-Family Kinases; Vascular Endothelial Growth Factor Receptor-2; Zebrafish

2015

Human melanoma TrkC: its association with a purine-analog-sensitive kinase activity.

Journal of cellular biochemistry, 2003, Apr-01, Volume: 88, Issue:5

Topics: 2-Aminopurine; Brain Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Melanoma; Neoplasm Metastasis; Neurotrophin 3; Protein Kinases; Protein Serine-Threonine Kinases; Receptor, Nerve Growth Factor; Receptor, trkC; Receptors, Nerve Growth Factor; Signal Transduction; Thioguanine; Time Factors

2003